Tielman Van Vleck

Tielman received his Ph.D. from Columbia in Biomedical Informatics, focusing on NLP-based machine learning. He helped start clinical NLP company Clinithink before joining Sinai to focus on using NLP for deep phenotyping and related discovery.

Dr. Van Vleck's research currently focuses on leveraging NLP techniques to identify patient features not captured in ordinary structured data to understand long-term Covid symptoms and train models predicting outcomes.